You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation
|
---|---|
Published in |
Stem Cell Research & Therapy, December 2011
|
DOI | 10.1186/scrt89 |
Pubmed ID | |
Authors |
Tayaramma Thatava, Adam S Armstrong, Josep Genebriera De Lamo, Ramakrishna Edukulla, Yulia Krotova Khan, Toshie Sakuma, Seiga Ohmine, Jamie L Sundsbak, Peter C Harris, Yogish C Kudva, Yasuhiro Ikeda |
Abstract |
End-stage renal disease (ESRD) is a major public health problem. Although kidney transplantation is a viable therapeutic option, this therapy is associated with significant limitations, including a shortage of donor organs. Induced pluripotent stem (iPS) cell technology, which allows derivation of patient-specific pluripotent stem cells, could provide a possible alternative modality for kidney replacement therapy for patients with ESRD. |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Iran, Islamic Republic of | 1 | 1% |
Japan | 1 | 1% |
Unknown | 65 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 21 | 31% |
Researcher | 14 | 21% |
Student > Bachelor | 7 | 10% |
Student > Master | 6 | 9% |
Student > Doctoral Student | 2 | 3% |
Other | 6 | 9% |
Unknown | 11 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 19 | 28% |
Medicine and Dentistry | 13 | 19% |
Biochemistry, Genetics and Molecular Biology | 6 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Engineering | 3 | 4% |
Other | 10 | 15% |
Unknown | 13 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2013.
All research outputs
#15,239,825
of 22,659,164 outputs
Outputs from Stem Cell Research & Therapy
#1,326
of 2,410 outputs
Outputs of similar age
#162,643
of 240,733 outputs
Outputs of similar age from Stem Cell Research & Therapy
#3
of 6 outputs
Altmetric has tracked 22,659,164 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,410 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,733 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.